1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The biotechnology reagents market is forecasted to grow by USD 40.26 billion during 2023-2028, accelerating at a CAGR of 7.81% during the forecast period. The report on the biotechnology reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high usage of biotechnology reagents in diagnostic and therapeutic applications, increasing research and development investments by federal agencies and biotechnology firms, and presence of high throughput and novel technologies.
The biotechnology reagents market is segmented as below:
By Technology
- Chromatography
- In-vitro diagnostics
- Polymerase chain reaction
- Cell culture
- Others
By Application
- Protein synthesis and purification
- Gene expression
- DNA and RNA analysis
- Drug testing
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing stem cell and biomedical research as one of the prime reasons driving the biotechnology reagents market growth during the next few years. Also, increasing focus on emerging economies and industry developments will lead to sizable demand in the market.
The report on the biotechnology reagents market covers the following areas:
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high usage of biotechnology reagents in diagnostic and therapeutic applications, increasing research and development investments by federal agencies and biotechnology firms, and presence of high throughput and novel technologies.
The biotechnology reagents market is segmented as below:
- Biotechnology reagents market sizing
- Biotechnology reagents market forecast
- Biotechnology reagents market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Technology
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global biotechnology reagents market: Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., F. Hoffmann La Roche Ltd., Illumina Inc., Lonza Group Ltd., Merck KGaA, Meridian Bioscience Inc., New England Biolabs Inc., Perkin Elmer Inc., Promega Corp., QIAGEN NV, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Tosoh Corp., and Waters Corp..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing stem cell and biomedical research."
According to the report, one of the major drivers for this market is the high usage of biotechnology reagents in diagnostic and therapeutic applications.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Agilent Technologies Inc.
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- bioMerieux SA
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- Illumina Inc.
- Lonza Group Ltd.
- Merck KGaA
- Meridian Bioscience Inc.
- New England Biolabs Inc.
- Perkin Elmer Inc.
- Promega Corp.
- QIAGEN NV
- Siemens AG
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
- Tosoh Corp.
- Waters Corp.
